Evidence map›Paper›PMID 31636686›Full record

ReviewEvidence-based complementary and alternative medicine : eCAM2019

Therapeutic Effects of Ten Commonly Used Chinese Herbs and Their Bioactive Compounds on Cancers.

Wei Liu, Binbin Yang, Lu Yang, Jasmine Kaur, Calvin Jessop, Rushdi Fadhil, David Good, Guoying Ni, Xiaosong Liu, Tamim Mosaiab and 2 more

Open access · hybridAbstract readReview
In one paragraph

Review in Evidence-based complementary and alternative medicine : eCAM, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Immunoradiotherapy for NSCLC: mechanisms, clinical outcomes, and future directions.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2024
    Review
  3. Combination ofFrontiers in pharmacology · 2024
    Article
  4. RSC advances · 2023
    Article
  5. Review
  6. Review
  7. Evodiamine suppresses non-small cell lung cancer by elevating CD8Journal of experimental & clinical cancer research : CR · 2020
    Article
  8. Bioactive CMolecules (Basel, Switzerland) · 2020
    Review
  9. Article
  10. Review
  11. Journal of evidence-based integrative medicine
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Wei LiuDepartment of Laboratory Medicine, Key Laboratory of Clinical Laboratory Diagnostics in Universities of Shandong, Weifang Medical University, 261053 Weifang, Shandong, China.ORCID https://orcid.org/0000-0002-2616-4869
Binbin YangDepartment of Laboratory Medicine, Key Laboratory of Clinical Laboratory Diagnostics in Universities of Shandong, Weifang Medical University, 261053 Weifang, Shandong, China.
Lu YangDepartment of Laboratory Medicine, Key Laboratory of Clinical Laboratory Diagnostics in Universities of Shandong, Weifang Medical University, 261053 Weifang, Shandong, China.
Jasmine KaurSchool of Medical Science & Menzies Health Institute Queensland, Griffith University, Brisbane, Australia.
Calvin JessopSchool of Medical Science & Menzies Health Institute Queensland, Griffith University, Brisbane, Australia.
Rushdi FadhilSchool of Medical Science & Menzies Health Institute Queensland, Griffith University, Brisbane, Australia.
David GoodSchool of Medical Science & Menzies Health Institute Queensland, Griffith University, Brisbane, Australia.ORCID https://orcid.org/0000-0002-8758-2124
Guoying NiSchool of Medical Science & Menzies Health Institute Queensland, Griffith University, Brisbane, Australia.ORCID https://orcid.org/0000-0002-7410-5900
Xiaosong LiuCancer Research Institute, Guangdong Pharmaceutical University, Guangzhou, China.ORCID https://orcid.org/0000-0001-9697-4536
Tamim MosaiabSchool of Medical Science & Menzies Health Institute Queensland, Griffith University, Brisbane, Australia.
Zhengjun YiDepartment of Laboratory Medicine, Key Laboratory of Clinical Laboratory Diagnostics in Universities of Shandong, Weifang Medical University, 261053 Weifang, Shandong, China.ORCID https://orcid.org/0000-0003-3922-3386
Ming Q WeiSchool of Medical Science & Menzies Health Institute Queensland, Griffith University, Brisbane, Australia.ORCID https://orcid.org/0000-0002-1229-8786
Griffith University · AUUniversity of the Sunshine Coast · AUWeifang Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Effective cancer therapy is one of the biggest global challenges. Conventional cancer therapies have been at the forefront of combating cancers, but more evidence showed considerable side effects, limiting their use. There are various new therapies in development, but combined approaches for treating cancer are much expected. Natural herbs had been traditionally in use for cancer therapy in most parts of the world. In this review, we have examined ten commonly used Chinese herbs that have, for centuries, shown effectiveness in treating cancers. They demonstrated the abilities to promote the apoptosis of cancer cells, inhibit their metastasis, activate the patient's anticancer immunity, and synergistically increase the efficacy of conventional chemotherapy and radiation therapy when used in combination. Clinical experiences had proved that these herbs and their bioactive compounds were effective against a plethora of cancers through a variety of mechanisms, effectively improving patients' quality of life without significant side effects. These advantages indicate that there are huge potentials in the development of Chinese herbs into cancer medicine as part of a promising, holistic cancer treatment modality.

Identifiers

PMID31636686
PMCPMC6766161
OpenAlexW2972609946

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.